Error message

  • Deprecated function: Creation of dynamic property MergeQuery::$condition is deprecated in MergeQuery->__construct() (line 1357 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).

Sun Pharmaceutical gets tentative nod from USFDA for ‘Optivar Solution’

Sun Pharmaceutical gets tentative nod from USFDA for ‘Optivar Solution’Sun Pharmaceutical Industries Ltd, a leading India based drug major has informed that it has received tentative approval from USFDA for company's

Abbreivated New Drug Application (ANDA) for generic Optivar, azelastine ophthalmic solution 0.05%.

The pharmaceutical firms stated in a communiqué that sterile azelastine hydrochloride ophthalmic solution is the therapeutically equivalent to Optivar Opthalmic Solution 0.05% of Medpointe Pharmaceuticals.

Reports suggest that the product has annual sales of approximately $48 million in the US. Azelastine is a selective antihistamine, which used for the treatment of the itching of the eyes associated with allertic conjunctivitis.

Ahead of positive announcement, the scrip of the company today closed on BSE, with gain of Rs 28 or 2.46% at Rs 1146.

Error | TopNews

Under Maintenance

The website encountered an unexpected error. Please try again later.